Course Content
🧬 Theme I — Molecules and Bacteria
🧬 Theme II — Aging and Death
Foundation-II Module — 3rd Year MBBS
AIM • KMU EXAM PRACTICE

KMU Past Paper Practice

Pharmacodynamics, Drug Receptors and Dose–Response Relationships

3rd Year MBBS • 20 A-Type Single Best Answer MCQs

Curriculum and assessment scope derived from the supplied AIM prompt. :contentReference[oaicite:0]{index=0}

MCQ 1

Question:

A manufacturer produces two batches of a hormone preparation containing the same measured chemical concentration. One batch produces a weaker response in isolated tissue. Which procedure would best establish whether the two batches have equivalent functional strength?

Options:

Measurement of molecular weight
Comparison by biological response
Determination of solution density
Assessment of tablet hardness
Measurement of melting point
Correct Answer: Comparison by biological response
Explanation: Equal chemical concentration does not guarantee equal biological activity; bioassay directly compares functional potency in a biological system.

MCQ 2

Question:

During quality control, a biological product is repeatedly compared with an accepted reference so that each batch has a predictable strength and activity. Which process is being performed?

Options:

Receptor characterization
Dose escalation
Standardization
Quantal analysis
Receptor regulation
Correct Answer: Standardization
Explanation: Standardization ensures that a preparation maintains defined potency or activity by comparison with an accepted reference.

MCQ 3

Question:

In a three-point bioassay, a test preparation produces a response of 45 units. Two standard doses produce responses of 30 and 60 units. Why are these two standard doses suitable for estimating the test potency?

Options:

They produce identical biological responses
They eliminate biological variation completely
They measure the chemical concentration directly
They bracket the response of the test preparation
They determine the maximum tissue response
Correct Answer: They bracket the response of the test preparation
Explanation: In a three-point bioassay, the test response should lie between the responses to the lower and higher standard doses so relative potency can be estimated.

MCQ 4

Question:

A new antiarrhythmic drug does not bind to a classical receptor. Instead, it alters movement of sodium ions across the cardiac cell membrane. Which cellular target is most directly involved?

Options:

Intracellular enzyme
Nuclear receptor
Membrane transporter
Structural protein
Ion channel
Correct Answer: Ion channel
Explanation: Direct alteration of transmembrane sodium movement is characteristic of drug action at an ion channel rather than at a conventional ligand receptor.

MCQ 5

Question:

A drug inhibits a membrane protein responsible for returning a neurotransmitter from the synaptic cleft into the presynaptic neuron. Which type of pharmacological target is being inhibited?

Options:

Transporter
Second messenger
Orphan receptor
Structural protein
Intracellular ligand
Correct Answer: Transporter
Explanation: Reuptake proteins move neurotransmitters across cell membranes and are pharmacological transporter targets.

MCQ 6

Question:

A vasodilator activates a signaling pathway that increases intracellular cyclic GMP in vascular smooth muscle. Which consequence is most consistent with this second-messenger response?

Options:

Activation of protein kinase A
Release of acetylcholine
Smooth-muscle relaxation
Receptor internalization
Formation of IP3
Correct Answer: Smooth-muscle relaxation
Explanation: cGMP activates cGMP-dependent signaling that promotes relaxation of vascular smooth muscle.

MCQ 7

Question:

In an endocrine cell, receptor activation causes release of calcium from intracellular stores. The rise in cytosolic calcium then stimulates secretion. Which role is calcium performing in this sequence?

Options:

Receptor antagonist
Extracellular agonist
Membrane transporter
Second messenger
Competitive ligand
Correct Answer: Second messenger
Explanation: Intracellular Ca2+ carries the signal from receptor activation to downstream cellular processes such as secretion or contraction.

MCQ 8

Question:

A very small amount of an agonist produces a disproportionately large cellular effect because one activated receptor initiates activation of many downstream molecules. Which pharmacodynamic property explains this observation?

Options:

Drug specificity
Signal amplification
Chemical antagonism
Receptor down-regulation
Quantal variation
Correct Answer: Signal amplification
Explanation: Intracellular signaling cascades amplify receptor activation by allowing one receptor event to influence many downstream molecules.

MCQ 9

Question:

A pharmacologist must compare drug responses across concentrations ranging from 0.001 to 100 units. Plotting the arithmetic doses compresses the lower values and makes comparison difficult. Which modification is most useful?

Options:

Remove the low-dose values
Plot only maximal responses
Convert responses into percentages
Use a logarithmic dose scale
Replace dose with receptor number
Correct Answer: Use a logarithmic dose scale
Explanation: A log-dose scale displays a wide dose range conveniently and produces a sigmoid curve whose central portion is easier to compare.

MCQ 10

Question:

Two agonists are plotted on the same log dose-response graph. Their curves are parallel and reach the same height, but one is displaced horizontally. Which parameter can be compared most directly from the horizontal separation?

Options:

Lethal dose
Therapeutic window
Relative potency
Protective index
Population variability
Correct Answer: Relative potency
Explanation: Horizontal displacement of curves with the same Emax reflects differences in the concentration required for a given effect and therefore relative potency.

MCQ 11

Question:

In a population study, increasing doses of a drug are assessed for the occurrence of a predefined toxic effect. At 25 mg, exactly half of the subjects develop the toxic endpoint. Which pharmacological value is represented by 25 mg?

Options:

ED50
TD50
Emax
LD50
ED99
Correct Answer: TD50
Explanation: TD50 is the dose that produces a specified toxic effect in 50% of the studied population.

MCQ 12

Question:

During experimental drug evaluation, investigators report that a dose of 80 mg causes death in half of the experimental population. Which term describes this value?

Options:

Protective dose
Median toxic dose
Maximum effective dose
Median lethal dose
Minimum toxic dose
Correct Answer: Median lethal dose
Explanation: LD50 is the median lethal dose, defined as the dose producing death in 50% of an experimental population.

MCQ 13

Question:

Two drugs have similar therapeutic effects. Drug P has TD50 of 100 mg and ED50 of 20 mg. Drug Q has TD50 of 200 mg and ED50 of 20 mg. Which statement follows from these data?

Options:

Drug P has greater efficacy
Drug P has greater potency
Drug Q has the larger therapeutic index
Drug Q has lower receptor affinity
Both drugs have equal safety indices
Correct Answer: Drug Q has the larger therapeutic index
Explanation: TI for Drug P is 100/20 = 5, whereas TI for Drug Q is 200/20 = 10; Drug Q therefore has the larger numerical safety margin.

MCQ 14

Question:

A pharmacologist wants a safety measure that is more stringent than comparing median effective and median toxic doses. Which comparison would provide the more demanding estimate?

Options:

ED50 with Emax
TD50 with LD50
ED50 with LD50
TD1 with ED99
Emax with TD50
Correct Answer: TD1 with ED99
Explanation: The protective index uses TD1/ED99, asking whether toxicity in sensitive individuals overlaps with doses needed to treat almost the entire population.

MCQ 15

Question:

A student compares digoxin with a drug whose therapeutic concentrations are much farther from toxic concentrations. Which property of digoxin is most important when interpreting this difference?

Options:

Higher receptor efficacy
Narrow safety margin
Greater drug specificity
Reduced receptor affinity
Lower pharmacological potency
Correct Answer: Narrow safety margin
Explanation: Digoxin is a classic narrow-therapeutic-index drug, so useful and toxic exposures lie relatively close together.

MCQ 16

Question:

A drug acts mainly on one receptor subtype at low concentrations but begins to affect several additional targets as its concentration rises. Which statement best describes the difference between selectivity and specificity illustrated by this finding?

Options:

Selectivity is relative, whereas absolute specificity is uncommon
Specificity is determined only by therapeutic index
Selectivity increases as additional targets are occupied
Specificity and potency describe the same property
Selectivity depends only on maximal efficacy
Correct Answer: Selectivity is relative, whereas absolute specificity is uncommon
Explanation: Selectivity is preferential rather than absolute and commonly decreases as concentration rises; true action on only one target is uncommon.

MCQ 17

Question:

Drug A has an ED50 of 2 mg and produces a maximum response of 60 units. Drug B has an ED50 of 10 mg and produces a maximum response of 100 units. A patient requires the greatest achievable therapeutic response. Which drug property should guide the choice most strongly?

Options:

Lower ED50 of Drug A
Greater potency of Drug A
Greater efficacy of Drug B
Lower dose requirement of Drug A
Greater concentration range of Drug B
Correct Answer: Greater efficacy of Drug B
Explanation: When the clinical goal is the greatest achievable effect, efficacy is more important than potency; Drug B reaches the higher Emax.

MCQ 18

Question:

In an isolated tissue preparation, an antagonist is added before an agonist. The agonist can still achieve its original maximum response, but only after a several-fold increase in concentration. Which property of the agonist has been altered most directly?

Options:

Maximum efficacy
Apparent potency
Intrinsic specificity
Therapeutic index
Biological standardization
Correct Answer: Apparent potency
Explanation: Preserved Emax with a higher agonist concentration requirement indicates reduced apparent potency, the characteristic effect of surmountable competitive blockade.

MCQ 19

Question:

An antagonist reduces the maximum response to an agonist. Increasing the agonist concentration produces only a partial recovery because a proportion of functional receptor signaling remains unavailable. Which interpretation best fits this finding?

Options:

The agonist has become more potent
The antagonist has increased receptor number
The antagonist has reduced available response capacity
The agonist has gained receptor specificity
The tissue has undergone standardization
Correct Answer: The antagonist has reduced available response capacity
Explanation: Non-competitive interference reduces the functional receptor-response system, so additional agonist cannot fully restore the original Emax.

MCQ 20

Question:

A pharmacologist compares two methods of evaluating a new drug. One records the magnitude of blood-pressure reduction in each subject, while the other records the percentage of subjects who achieve a predefined adequate response. What additional information is provided by the second method?

Options:

Exact receptor affinity
Maximum tissue efficacy
Chemical purity of the drug
Distribution of a defined response in a population
Number of spare receptors
Correct Answer: Distribution of a defined response in a population
Explanation: Quantal analysis shows what proportion of a population achieves a predefined endpoint, information that a graded individual-response curve does not provide.
Scroll to Top
💬 WhatsApp Support